 "Anuh Pharma surges on receiving WHO prequalification for Sulfadoxine")
Anuh Pharma has rallied 9% to Rs 339 on the BSE in early morning trade after the pharmaceutical company said that it has received World Health Organization (WHO) prequalification for the product Sulfadoxine.
The company last week received Good Manufacturing Practice (GMP) certificate from COFEPRIS (Health Authority of Mexico) for two products - Chloramphenicol and Chloramphenicol Palmitate.
Anuh Pharma is one of the largest manufacturers of Macrolides and Anti-TB products in India, besides being a major player in Anti-bacterials, Anti-malarial, Antihypertension and Corticosteroids.
At 09:34 am, the stock was up 6% at Rs 332 on the BSE. About 24,000 equity shares have already changed hands on the counter so far against an average 29,000 shares were traded daily in past two weeks on the BSE.
The company last week received Good Manufacturing Practice (GMP) certificate from COFEPRIS (Health Authority of Mexico) for two products - Chloramphenicol and Chloramphenicol Palmitate.
Anuh Pharma is one of the largest manufacturers of Macrolides and Anti-TB products in India, besides being a major player in Anti-bacterials, Anti-malarial, Antihypertension and Corticosteroids.
At 09:34 am, the stock was up 6% at Rs 332 on the BSE. About 24,000 equity shares have already changed hands on the counter so far against an average 29,000 shares were traded daily in past two weeks on the BSE.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%